Le Lézard
Classified in: Business

RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer

TORONTO, Dec. 09, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the "Company" or "RAMM") (CSE: RAMM), is pleased to announce the appointment of José Roldan as interim-Chief Financial Officer of the Company, effective immediately. Mr Roldan succeeds Mr. Guillermo Delmonte who is currently on medical leave.

Mr. Roldan is a Public Accountant specializing in audits of financial and commercial institutions. He has extensive experience in the cannabis space coupled with knowledge of central bank regulations and International Financial Reporting Standards. Prior to joining RAMM, Mr. Roldan worked as a senior auditor with KPMG Uruguay for six years.

About RAMM Pharma Corp.

RAMM Pharma is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other hemp-based products with a unique and diversified international production and sales platform. The Company operates an established pharmaceutical and medical product business in Uruguay that has developed several medically registered and approved plant-derived cannabinoid pharmaceutical products that have been authorized for sale and/or compassionate use in several Latin American countries. RAMM also has a pipeline of new products, including registered hemp-based nutrition and specialized veterinary products, in various stages of approval and development, which are produced at the company's state-of-the-art, good-manufacturing-practice-certified formulation facility in Montevideo, Uruguay.

In Europe, RAMM's vertically integrated operations are based in Ragusa, Italy and Elbl?g, Poland (60 kilometres east of Gda?sk), and include a hemp cultivation platform, and large extraction and processing facilities (in the final stages of commissioning in the case of Canapar Corp.).

RAMM Pharma includes wholly owned subsidiaries Canapar Corp., HemPoland S.p.a. Z.o.o., Medic Plast SA, Yurelan SA, Glediser SA and RAMM Pharma Holdings Corp.

Additional information about the Company is available at www.rammpharma.com.

For further information, please contact:

Jimena Reyes
Executive Assistant
+598 2513 99 58

These press releases may also interest you

at 14:30
Building a strong economy means supporting businesses as they adapt, grow and seek out new economic opportunities. In the Northwest Territories (NWT), Indigenous and Northern businesses are building a path forward through creativity, new ideas and...

at 14:30
Officials from Rendina Healthcare Real Estate ("Rendina") and Baptist Memorial Health Care ("Baptist") assembled earlier this month to celebrate the grand opening of its new Baptist Arlington Emergency Department in Arlington, Tenn. The new...

at 14:30
Big Thirst, the spirits industry's most comprehensive e-commerce sales and marketing company, is expanding its services to offer an online marketplace and additional distillation production consulting services. Shop Big Thirst is a new...

at 14:27
St. Thomas University (STU) has begun the search for its next College of Law Dean. The national search will be conducted in partnership with Korn Ferry, a global organizational consulting firm, and an advisory committee. The Dean Search Committee...

at 14:25
PrideStaff, a nationally franchised staffing organization, is pleased to announce that their San Diego office was named one of the top temporary staffing agencies for 2022 by the San Diego Business Journal. Each year, the Temporary Placement...

at 14:22
Employers' Forum of Indiana recently announced the first major data update to its nationwide hospital price tool, Sage Transparencytm, a free, customizable dashboard that compares metrics of hospital and ASC quality, price, and cost across 4,000...

News published on 9 december 2022 at 16:30 and distributed by: